Work

Abstract PS3-10-07: Addressing unmet clinical need in HR-positive/HER2-negative early breast cancer: baseline profile of Italian patients included in a compassionate use program ribociclib plus NSAI

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-10-07

Authors: I. Viganò, A. Lunello, D. Valsecchi, N. Viapiana, A. Martinez-Fernandez

Institutions: Novartis (Italy), Novartis (Spain)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129435501

Cites:

Cited by:

Related to: